These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15304081)

  • 41. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
    Klanica K
    J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 44. [Conflict of interest in clinical research--trends in guidelines for research ethics in Japan and other countries].
    Tashiro M
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1130-5. PubMed ID: 21351693
    [No Abstract]   [Full Text] [Related]  

  • 45. [Financial conflict of interest in clinical psychiatry studies: a review].
    Ulaş H; Binbay T; Alptekin K
    Turk Psikiyatri Derg; 2008; 19(4):418-26. PubMed ID: 19110984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 48. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
    Jordan KA
    Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
    [No Abstract]   [Full Text] [Related]  

  • 49. Investigator, IRB and institutional financial conflicts in interest in human-subject research: past, present and future.
    Barnes M; Florencio PS
    Seton Hall Law Rev; 2003; 32(3):525-60. PubMed ID: 12741411
    [No Abstract]   [Full Text] [Related]  

  • 50. FDA issues concerning conflicts of interest.
    Kurt TL
    IRB; 1990; 12(5):6-9. PubMed ID: 11654003
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug buddies.
    Ledford H
    Nature; 2011 Jun; 474(7352):433-4. PubMed ID: 21697923
    [No Abstract]   [Full Text] [Related]  

  • 52. Conflicts of interest among committee members in the National Academies' genetically engineered crop study.
    Krimsky S; Schwab T
    PLoS One; 2017; 12(2):e0172317. PubMed ID: 28245228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The troublesome semantics of conflict of interest.
    Friedman PJ
    Ethics Behav; 1992; 2(4):245-51. PubMed ID: 11651613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ethical Guidelines for Clinical Trials in Medical Research Involving Human Subjects].
    Sone S
    Gan To Kagaku Ryoho; 2015 Aug; 42(8):893-902. PubMed ID: 26321701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A national survey of policies on disclosure of conflicts of interest in biomedical research.
    McCrary SV; Anderson CB; Jakovljevic J; Khan T; McCullough LB; Wray NP; Brody BA
    N Engl J Med; 2000 Nov; 343(22):1621-6. PubMed ID: 11096171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of academic scientists' responses to situations that pose a conflict of interest.
    Sax JK; Doran N
    Cancer Biol Ther; 2011 Jul; 12(1):4-8. PubMed ID: 21525792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tough-talking journal editor faces accusations of leniency.
    McNeil DG
    N Y Times Web; 2006 Aug; ():F1, F3. PubMed ID: 16906685
    [No Abstract]   [Full Text] [Related]  

  • 59. Institutional academic industry relationship: results of interviews with university leaders.
    Campbell EG; Moy B; Feibelmann S; Weissman JS; Blumenthal D
    Account Res; 2004; 11(2):103-18. PubMed ID: 15675051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.